Medical Nanotechnology: The Future of Targeted Treatment
Keywords:
nanomedicine, targeted drug delivery, cancer therapy, regenerative medicine, biomedical imagingAbstract
Medical nanotechnology has emerged as one of the most promising advancements in modern healthcare, offering precise, personalized, and minimally invasive treatment strategies. By manipulating materials at the nanoscale (1–100 nm), scientists can design nanoparticles that selectively target diseased cells, deliver therapeutic agents, and monitor treatment efficacy in real time. This paper explores the fundamental principles of medical nanotechnology, its current applications in targeted drug delivery, diagnostics, and regenerative medicine, and future prospects for addressing complex medical challenges. Emphasis is placed on its role in oncology, cardiovascular diseases, and neurological disorders, highlighting the potential for improved therapeutic outcomes and reduced side effects. The discussion also addresses regulatory, ethical, and safety considerations essential for translating nanotechnological innovations from laboratory research to clinical practice.
References
Irk, E. (2026). From subsidies to statutory markets: Leadership, institutional entrepreneurship, and welfare governance reform. https://doi.org/10.52152/s59sjh53
Ahmad, N. R. (2026). AI-enabled public governance in developing states: Service delivery gains, accountability risks, and a practical risk-based regulatory model. https://doi.org/10.52152/wja5db40